Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes
about
Incidence of chronic kidney disease among people with diabetes: a systematic review of observational studies.Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetesInpatient screening for albuminuria and retinopathy to predict long-term mortality in type 2 diabetic patients: a retrospective cohort study.A new Classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy.Predictors of all-cause and cardiovascular disease mortality in type 2 diabetes: Diabetes Heart Study.Regular exercise behavior is related to lower extremity muscle strength in patients with type 2 diabetes: Data from the Multicenter Survey of the Isometric Lower Extremity Strength in Type 2 Diabetes study.The Impact of Creatinine Clearance Rate, Daily Urinary Albumin, and Their Joint Effect on Predicting Death in Diabetic Inpatients After Discharge: An Observational Study.Nationwide multicentre kidney biopsy study of Japanese patients with type 2 diabetes.Association of serum uric acid levels with the risk of development or progression of albuminuria among Japanese patients with type 2 diabetes: a prospective cohort study [Diabetes Distress and Care Registry at Tenri (DDCRT 10)].Usefulness of morning home blood pressure measurements in patients with type 2 diabetes mellitus: results of a 10-year, prospective, longitudinal study.Microvascular complications and prevalence of urgency incontinence in Japanese patients with type 2 diabetes mellitus: The dogo study.Impact of kidney function and urinary protein excretion on intima-media thickness in Japanese patients with type 2 diabetes.One-year eGFR decline rate is a good predictor of prognosis of renal failure in patients with type 2 diabetes.Diabetic polyneuropathy is a risk factor for decline of lower extremity strength in patients with type 2 diabetes.Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy.Rationale and study design of a clinical trial to assess the effects of LDL apheresis on proteinuria in diabetic patients with severe proteinuria and dyslipidemia.Clinicopathological analysis of biopsy-proven diabetic nephropathy based on the Japanese classification of diabetic nephropathy.Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS.Albuminuria, serum creatinine, and estimated glomerular filtration rate as predictors of cardio-renal outcomes in patients with type 2 diabetes mellitus and kidney disease: a systematic literature review.Clinical and Pathological Significance of Autoantibodies to Erythropoietin Receptor in Type 2 Diabetic Patients With CKD.The renoprotective effect and safety of a DPP-4 inhibitor, sitagliptin, at a small dose in type 2 diabetic patients with a renal dysfunction when changed from other DPP-4 inhibitors: REAL trial.Effect of Sleep-Disordered Breathing on Albuminuria in 273 Patients With Type 2 Diabetes.Glucosuria and all-cause mortality among general screening participants.Albuminuria Increases All-Cause Mortality in Japanese Patients with Type 2 Diabetes MellitusEstimated glomerular filtration rate decline and risk of end-stage renal disease in type 2 diabetes
P2860
Q30238531-7083E2C5-4655-425B-BA49-14F7D2AA257CQ33583540-9724E4D1-4920-44CB-B4C8-826CFD3AF40FQ33634491-DB2A4436-A49E-4CE7-B45E-7C3D5E360312Q35192219-A13A39A7-7BA3-4DCC-B195-5913DFB2D834Q35814812-94977467-380F-422E-876F-EEFBEC8C98F8Q36405201-64E643C3-1C9F-4CF8-B047-91B07692A157Q36581168-0AECD31F-A26F-4F78-BC41-4A3FD2C7BAC8Q38878457-0FEDB36D-16F0-4F75-A37B-03A383EB86A1Q38900912-08B898C6-C220-48E7-A338-6FDD5238DB3EQ39200479-793DFEEA-22BB-446F-A53F-43502924A654Q41385505-096FD3E1-0F4F-4ACD-B396-4F2477EA31C9Q41490665-3A9DD4FF-AA27-4C81-8BF8-0F1D86A0B57CQ47155159-F713A3D4-31C2-43D0-83DE-234BA4124B1BQ47356243-5DC701FE-8663-4FAD-A46B-98DFC07951C4Q47562666-1870DBE4-94BC-4474-8D18-B767251FC7C0Q47592079-137667A7-B2BB-4AD3-9B74-02362325A08CQ47698251-09953523-431D-47DA-927C-D1E70289F147Q47827046-FD43B7B9-FBAD-46AB-8D05-A57C431F3DB0Q49199995-B72C4BC5-A3F5-40F2-9DF9-825EDF443516Q49409256-6D4B5589-7788-4E82-8481-045C8C5EFE14Q49592715-9D499D7A-A087-4329-B1E0-717A1AFE37EAQ49837425-C319D7FD-405D-4D55-A8CB-B8DEBEFB7A5FQ50057769-CAC55483-6A66-4AC8-867D-87868260FC5DQ58710551-7CB9C4A6-A3C2-4C3F-81B2-97AA91BABFBDQ58803772-9F79B86B-406E-437F-8B2C-9312D4EB189B
P2860
Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes
description
scientific article published on 17 October 2013
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2013
@uk
name
Clinical impact of albuminuria ...... patients with type 2 diabetes
@en
Clinical impact of albuminuria ...... patients with type 2 diabetes
@nl
type
label
Clinical impact of albuminuria ...... patients with type 2 diabetes
@en
Clinical impact of albuminuria ...... patients with type 2 diabetes
@nl
prefLabel
Clinical impact of albuminuria ...... patients with type 2 diabetes
@en
Clinical impact of albuminuria ...... patients with type 2 diabetes
@nl
P2093
P2860
P921
P1476
Clinical impact of albuminuria ...... patients with type 2 diabetes
@en
P2093
Akinori Hara
Eiji Kusano
Hirofumi Makino
Hiroki Yokoyama
Hiroyuki Nakamura
Kengo Furuichi
Kunitoshi Iseki
Masakazu Haneda
Masayuki Iwano
Miho Shimizu
P2860
P2888
P304
P356
10.1007/S10157-013-0879-4
P577
2013-10-17T00:00:00Z